Tsimoyiannis E C, Glantzounis G, Lekkas E T, Siakas P, Jabarin M, Tzourou H
Department of Surgery, G. Hatzikosta General Hospital, Ioannina, Greece.
Surg Laparosc Endosc. 1998 Dec;8(6):416-20.
After laparoscopic cholecystectomy, CO2 remains within the peritoneal cavity, commonly causing pain. This prospective randomized study was performed to determine the efficacy of intraperitoneal normal saline and bupivacaine infusion on postoperative pain after laparoscopic cholecystectomy. Three hundred patients were randomly assigned to one of six groups of 50 patients each. Group A patients served as controls. In group B patients, normal saline was infused under the right hemidiaphragm and suctioned after the pneumoperitoneum was deflated. After suction, a subhepatic closed drain was left for 24 h. In group C patients, bupivacaine 1.5 mg/kg in solution 2.5 mg/ml, minus 15 ml of this solution, which was infiltrated in the trocar wounds, was infused under the right hemidiaphragm at the end of the cholecystectomy. In group D patients, bupivacaine was given as in group C, but a subhepatic drain was left for 24 h. In group E patients, normal saline was used as in group B plus bupivacaine as in group C. Group F patients were treated as in group E, but a subhepatic drain was left for 24 h. In all groups, 15 ml of a 2.5 mg/ml bupivacaine solution was infiltrated in the trocar wounds. Postoperatively, analgesic medication usage, nausea, vomiting, and pain scores were recorded at 2, 6, 12, 24, 36, 48, and 72 h. Postoperative pain was reduced significantly in the patients of the treatment groups vs. the controls. Between treatment groups, patients in groups B, E, and F had the best results, while those in groups C and D had significantly greater pain than those in groups B, E, and F. It is concluded that postoperative pain after laparoscopic cholecystectomy can be significantly reduced by intraperitoneal normal saline infusion subdiaphragmatically and after its postdeflation suction, bupivacaine infusion in the same area, or without bupivacaine in case a subhepatic drainage has been needed.
腹腔镜胆囊切除术后,二氧化碳残留于腹腔内,通常会引起疼痛。本前瞻性随机研究旨在确定腹腔内注入生理盐水和布比卡因对腹腔镜胆囊切除术后疼痛的疗效。300例患者被随机分为6组,每组50例。A组患者作为对照组。B组患者在右膈下注入生理盐水,气腹放气后吸出。吸出后,在肝下留置闭式引流管24小时。C组患者在胆囊切除术后,于右膈下注入2.5mg/ml溶液中含1.5mg/kg布比卡因,减去15ml该溶液,将其注入套管针伤口。D组患者给予与C组相同的布比卡因,但在肝下留置引流管24小时。E组患者采用与B组相同的生理盐水注入方法,并采用与C组相同的布比卡因注入方法。F组患者的治疗方法与E组相同,但在肝下留置引流管24小时。所有组均在套管针伤口处注入15ml 2.5mg/ml布比卡因溶液。术后分别在2、6、12、24、36、48和72小时记录镇痛药物使用情况、恶心、呕吐及疼痛评分。与对照组相比,各治疗组患者的术后疼痛明显减轻。在各治疗组之间,B组、E组和F组患者效果最佳,而C组和D组患者疼痛明显高于B组、E组和F组。结论是腹腔镜胆囊切除术后的疼痛可通过膈下腹腔内注入生理盐水并在放气后吸出、在同一区域注入布比卡因,或在需要肝下引流时不使用布比卡因而显著减轻。